Patient Guide: A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 54 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06491914
Status: ACTIVE_NOT_RECRUITING
Condition: Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema
Phase: PHASE3

Find a Study Location Near You

This study is available at 54 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Arcadia, California
  • Bakersfield, California
  • Beverly Hills, California
  • • And 51 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily